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Abstract 
Human γD-crystallin (HγD) is an abundant two-domain protein concentrated in the core region 
of the eye lens. Destabilizing mutations and post-translational modifications in the N-terminal 
domain of γ-crystallins are linked to onset of aggregation that causes cataract disease (lens 
turbidity). WT HγD greatly accelerates aggregation of the cataract-related W42Q variant, 
without itself aggregating. The mechanism of this “inverse prion” catalysis of aggregation 
remained unknown. Here we provide evidence that it proceeds via an early unfolding 
intermediate with an opened domain interface, which enables transient dimerization of WT and 
mutant, or mutant and mutant, HγD molecules at their C-terminal domains. This dimerization 
deprives the N-terminal domain of intramolecular stabilization by the domain interface and thus 
promotes its conversion to a distinct, aggregation-prone partially unfolded intermediate. This 
mechanism can be generalized to explain how surprising reactions, such as conformational 
catalysis of misfolding, may arise from simple domain-domain interactions in multidomain 
proteins. 
 
Significance 
Most known proteins in nature consist of multiple domains. Interactions between domains may 
lead to unexpected folding and misfolding phenomena. This study of human γD-crystallin, a 
two-domain protein in the eye lens, revealed one such surprise: conformational catalysis of 
misfolding via intermolecular domain interface “stealing.” An intermolecular interface between 
the more stable domains outcompetes the native intramolecular domain interface. Loss of the 
native interface in turn promotes misfolding and subsequent aggregation, especially in cataract-
related γD-crystallin variants. This phenomenon is likely a contributing factor in the 
development of cataract disease, the leading worldwide cause of blindness. However, interface 
stealing likely occurs in many proteins composed of two or more interacting domains.  
 
Introduction 
Beyond the native and fully unfolded states, most proteins can adopt partially unfolded or 
misfolded intermediates. Intermediates are especially important for multidomain proteins, which 
comprise most eukaryotic proteins yet only a small minority of biophysical studies to-date (1-3). 
These intermediates are often rare or transient and thus challenging to investigate, yet they have 
large effects on the protein’s stability, evolution, and function. Misfolded intermediates can 
dominate folding pathways (4-7), drive evolution of the coding sequence (8-10), and cause 
proteins to assemble into aggregates linked to common diseases (11-17). Post-translational 
modifications often affect the relative stabilities of intermediates within the conformational 
ensemble (18-24). However, where a protein is present at a high concentration, the question 
arises: Can distinct intermediate states interact or affect one another in a functionally significant 
way? Here we present experimental evidence that domain interface opening in one molecule of a 
stable two-domain protein can catalyze domain misfolding in another. 
Lens crystallins are extremely long-lived. Human γD-crystallin (HγD) in the core region of the 
eye lens is synthesized in utero and never replaced thereafter. It is extremely thermodynamically 
and kinetically stable, likely an evolutionary adaptation to resist aggregation (17, 25-28). 
However, crystallins accumulate damage throughout life, even as the cytoplasm of aged lens 
cells becomes increasingly oxidizing (29-36). Eventually, aggregation-prone partially unfolded 
intermediates arise, notably those locked by non-native disulfides (33, 37-43). Cataract is lens 
opacity that results when these misfolded crystallins assemble into light-scattering aggregates, 
making the lens turbid. Cataract is a disease of aging, affecting 17% of all people aged 40 and 
over (44, 45), though many congenital or early-onset mutations are also known (46, 47). Due to 
the high cost of surgery and lack of a therapeutic treatment, cataract remains the leading cause of 
blindness in the world (45, 48). 
HγD consists of two homologous double-Greek key domains joined by a non-covalent domain 
interface (49, 50). This interface contributes significantly to the stability of the N-terminal 
domain (50-52). Destabilization and misfolding of the N-terminal domain under oxidizing 
conditions leads to an aggregation-prone intermediate state kinetically trapped by a non-native 
internal disulfide bond (41). Surprisingly, the highly stable wild-type HγD promotes aggregation 
of its destabilized W42Q variant without itself aggregating – an interaction that may permit even 
a minor fraction of damaged molecules to cause significant lens turbidity (53).  
We have previously reported the crucial interplay between misfolding and disulfide exchange in 
the aggregation of cataract-associated HγD variants (42). Specifically,. we  showed that HγD 
molecules can exchange disulfide bonds dynamically in solution, which leads to the “hot potato” 
model: if a molecule with a destabilized N-terminal domain accepts a disulfide bond from a more 
stable molecule, aggregation of the destabilized variant will ensue (42). However, we now 
demonstrate that the wild-type protein also promotes aggregation of multiple cataract-related 
variants of HγD by a distinct mechanism independent of “hot potato” disulfide exchange. This 
novel mechanism is associated with a partially unfolded intermediate in the wild-type protein 
wherein the domain interface is opened. Population of this intermediate enables a transient 
“interface stealing” interaction between molecules such that the N-terminal domain of the 
aggregation-prone variant loses its interface with the C-terminal domain and hence the kinetic 
and thermodynamic stabilization derived from that interface. Thus, the interaction facilitates 
unfolding of the mutant’s N-terminal domain leading to its conformational transformation and 
aggregation. We refer to this new class of protein-protein interactions as conformational catalysis 
of misfolding via transient interaction of non-native states. 
Results 
Conformational catalysis of W42Q aggregation 
The W42Q variant of HγD mimics UV-induced damage to a Trp residue and shows significant 
propensity to aggregate at physiological temperature and pH, similar to the congenital-cataract 
mutant W42R (41, 43, 54). This aggregation process requires formation of a non-native internal 
disulfide bond (Cys32-Cys41), which traps the protein in a non-native “hairpin extruded” 
conformation (41). Because of this requirement of oxidation combined with misfolding, 
aggregation does not occur in the absence of oxidizing agent (41, 42).  
When the oxidizing agent glutathione disulfide (GSSG) was present in the buffer, aggregation of 
W42Q proceeded readily at 37 °C and pH 7 in a concentration-dependent manner (Fig. 1A). We 
have previously shown that a disulfide in wild-type HγD (Cys108-Cys110) is able to replace 
GSSG as oxidizing agent for W42Q aggregation (42). We investigated whether presence of WT 
produced any further effect on W42Q aggregation when excess GSSG was also present in the 
buffer. Presence of WT led to dramatic, [WT]-dependent acceleration of W42Q aggregation 
despite the excess GSSG (Fig. 1B). Adding more GSSG did not significantly affect aggregation 
(Fig. 1C). This finding indicated that there exists a distinct, redox-independent mechanism by 
which WT promotes aggregation of W42Q which is not related to disulfide transfer from WT to 
aggregation prone variant.  
We previously found that, in the absence of any other oxidant in the buffer, removal of Cys108 
or Cys110 from the WT rendered it unable to promote aggregation of W42Q (42). However, 
when excess GSSG was present in the buffer, removing any Cys residue from the WT protein by 
site-directed mutagenesis did not abolish WT-induced acceleration of the aggregation rate, and 
often actually enhanced it (Fig. 1D). Furthermore, it did not matter whether the WT protein was 
oxidized or reduced – as long as a source of disulfides was present in excess, aggregation in the 
WT/W42Q mixture was rapid (Fig. S1). Thus, redox chemistry was not the basis for the 
accelerated aggregation. 
To investigate whether the increase in solution turbidity was due to increased W42Q aggregation 
or to co-aggregation of WT and W42Q, we determined the composition of the aggregated 
fraction. To that end we used a previously established PEGylation assay (42) to determine the 
total number of Cys residues per protein molecule in soluble vs. aggregated fractions of W42Q 
mixed with one of two multi-Cys mutants in the WT background. The variants used were 
C18T/C41A/C78A (“CCC”) and C18T/C78A/C108S/C110S (“CCCC”). Like WT, both variants 
promoted W42Q aggregation (Fig. 1D). Importantly, both CCC and CCCC variants remained 
entirely within the soluble supernatant fraction at the end of the aggregation reaction, while the 
majority of W42Q transferred to the aggregated fraction (Fig. 1E). All samples were reduced 
prior to PEGylation, hence W42Q reacted with 6 molecules of PEG-maleimide per protein 
molecule; a minor band at 4 PEG-maleimide per protein molecule indicates reduction was not 
complete. As a complementary experimental approach, we examined the composition of soluble 
and aggregated fractions in W42Q/WT mixtures by MALDI-TOF mass spectrometry, which 
likewise showed only W42Q in the aggregated fraction and WT in the supernatant (Fig. S2). We 
conclude that the increase in solution turbidity in W42Q/WT or W42Q/CCC or W42Q/CCCC 
mixtures was not due to co-aggregation, but rather to increased aggregation of the W42Q variant. 
 
 
Fig. 1: WT HγD promotes aggregation of the W42Q variant in a catalytic, redox-
independent manner. (A) W42Q HγD aggregated in a concentration-dependent manner in the 
presence of excess glutathione disulfide (GSSG). (B) WT promoted aggregation of W42Q in a 
[WT]-dependent manner. (C) Further excess of GSSG did not significantly affect W42Q 
aggregation. (D) Mutagenesis of any given Cys residue, or the combination of 
C18T/C41A/C78A (“CCC”) or C18T/C78A/C108S/C110S (“CCCC”) in the WT background did 
not abolish its ability to promote W42Q aggregation at saturating GSSG, and indeed enhanced it. 
A control protein (lysozyme) did not promote W42Q aggregation. Two replicates are shown as 
illustration of reproducibility. (E) Cys-counting analysis of the starting (“START”), aggregated 
(“PEL”), and supernatant (“SUP”) fractions of W42Q/CCC and W42Q/CCCC mixtures. The 
W42Q variant contains 6 Cys residues and thus reacts with a maximum of 6 PEG-maleimide 
equivalents (4 if the internal disulfide required for aggregation has not been reduced). The CCC 
and CCCC variants contain only 3 and 2 Cys residues, respectively. Neither CCC not CCCC was 
detectable in the aggregated fraction, which is composed entirely of W42Q, indicating that the 
aggregation-promoting activity was catalytic. 
 
We hypothesized that presence of WT accelerated conformational dynamics of W42Q making it 
more amenable to convert to an aggregation competent conformation containing the non-native 
disulfide bond 32-SS-41 (41). To that end, time-resolved PEGylation was used to probe the 
effect of conformational catalysis on the structure and conformational dynamics of the W42Q N-
terminal domain. Since the N-terminal domain contains four Cys residues, three of which are 
buried in the domain core and the fourth in the domain interface, Cys accessibility is a good 
probe for foldedness of the domain. Samples from W42Q and a W42Q/CCCC mixture incubated 
in the presence of PEG-maleimide at 37 °C in native buffer were taken at fixed intervals, the 
PEGylation reagent quenched with free cysteine, and the proteins resolved by SDS-PAGE to 
quantify the distribution of singly and multiply PEGylated molecules (Fig. 2 and Fig. S3). The 
CCCC sample contains only two Cys residues, one buried in the N-terminal core and the other in 
the domain interface. In control samples of CCCC alone only one Cys residue was found to be 
reactive during an hour-long incubation (Fig. 2, gray). We assign this to the residue buried in the 
domain interface, Cys41; the kinetics of its reactivity is related to the kinetics of interface 
opening in this variant. By contrast, the W42Q protein reacted extensively with PEG-maleimide 
during the course of the incubation, and both initial and full PEGylation was achieved more 
rapidly in the W42Q/CCCC mixture than in W42Q alone (Fig. 2). The first reactive site (+1 
PEG) is assigned to Cys110, which is the only natively exposed and the most reactive thiol (35, 
42, 49). The second reactive site in W42Q (+2 PEG) may be Cys41, since its solvent exposure 
requires only opening of the domain interface, which occurs relatively easily (41, 52, 55). 
However, no definitive assignment has been made. Kinetics of reactivity at the second site, as 
well as for full unfolding (+6 PEG) were significantly faster in the presence vs. absence of the 
conformational catalyst. Flux through the intervening numbers of exposed thiols was 
comparable, however, suggesting that following exposure of the first (or possibly second) 
natively buried Cys residue unfolding becomes cooperative. We conclude that the aggregation-
catalyzing interaction between W42Q and CCCC has a structural basis: it increases the unfolding 
rate of the W42Q N-terminal domain. 
 
      
Fig. 2: WT protein accelerates transient unfolding of W42Q. W42Q unfolded more rapidly 
when CCCC was present (orange) than without CCCC (blue). PEGylation is a measure of 
solvent accessibility of buried Cys residues. Error bars show S.E.M. of 3-4 replicate 
measurements with independent quantitation by SDS-PAGE. Control experiments with CCCC 
alone show the reactivity of its only two Cys residues (gray). PEGylation gels are shown in Fig. 
S3. 
Kinetic model of conformationally catalyzed HγD aggregation 
Our findings point to a peculiar mechanism whereby WT protein can catalyze aggregation of 
mutant form without aggregating itself. To explore this effect more quantitatively, we developed 
a minimalist kinetic model as described below. 
For an aggregation-prone mutant (MUT), we consider the following four conformational states. 
N is the native state of the protein, which we define here as any state that is neither aggregation 
prone nor likely to catalyze aggregation. ICAT is an early conformational intermediate that is 
capable of catalyzing aggregation but is not itself aggregation prone. ISS is the disulfide-locked 
partially unfolded intermediate that is the aggregation precursor. A is the high molecular weight 
aggregate. The conformational conversions for conformationally catalyzed aggregation follow 
this scheme: 
𝑁
kCAT
⇄
k-CAT
𝐼𝐶𝐴𝑇 
𝑘𝑆𝑆
→ 𝐼𝑆𝑆  
𝑘𝐴
→ 𝐴  
Only MUT proceeds from ICAT to ISS. Since prior experiments have shown that ISS in W42Q 
forms at temperatures where no unfolding is observed (53), requires a non-native disulfide (41), 
and partitions quantitatively to the aggregated state (42), we assume that the rate-limiting step for 
aggregation is the ICAT to ISS conversion. We have previously shown that solution turbidity 
varies monotonically with amount of aggregated protein (53), so the rate of turbidity rise at a 
given early aggregation time point is proportional to the rate of aggregation. Equilibration 
between N and ICAT is rapid relative to the ICAT to ISS conversion, so we define the equilibrium 
constant KCAT = kCAT/k-CAT. Note that the value of each rate constant above is specific to the 
given mutant. We now consider the simplest kinetic models that describe the following three 
cases: 
Case I: No catalysis 
The simplest model in this case involves direct conversion of N to ISS without the need for the 
catalytic intermediate. 
𝑑[𝐼𝑆𝑆]
𝑑𝑡
= 𝑘𝑆𝑆[𝑁] − 𝑘𝐴[𝐼𝑆𝑆]
𝑛 
𝑑[𝐴]
𝑑𝑡
= 𝑘𝐴[𝐼𝑆𝑆]
𝑛 
The maximum rate of aggregation occurs when [ISS] is highest, that is, d([ISS])/dt = 0, so the 
dependence of maximum aggregation rate on starting concentration of the mutant is linear: 
𝑑[𝐴]
𝑑𝑡
|
𝑚𝑎𝑥
= 𝑘𝑆𝑆[𝑁] 
Case II: Self-catalysis 
In this case the rate-limiting step is facilitated by an interaction between mutant molecules in the 
catalytic intermediate state. Hence: 
[𝐼𝐶𝐴𝑇] = 𝐾𝐶𝐴𝑇[𝑁] 
𝑑[𝐼𝑆𝑆]
𝑑𝑡
= 𝑘𝑠𝑠[ 𝐼𝐶𝐴𝑇]
𝑚 − 𝑘𝐴[𝐼𝑆𝑆]
𝑛 
𝑑[𝐴]
𝑑𝑡
= 𝑘𝐴[𝐼𝑆𝑆]
𝑛 
𝑑[𝐴]
𝑑𝑡
|
𝑚𝑎𝑥
= 𝑘𝑆𝑆[ 𝐼𝐶𝐴𝑇]
𝑚 ∝ [ 𝑁]𝑚 
Since the maximum aggregation rate occurs very early in the kinetic trace, [N] is approximately 
equal to the starting concentration. The KCAT is variant-specific. The simplest model is that the 
catalytic complex consists of only two ICAT molecules, so m = 2 – the dependence of maximum 
aggregation rate on starting concentration is quadratic. This is in very good agreement with 
experimental data shown in Fig. 3A. Fig. S4 shows the full aggregation traces for these variants 
and demonstrates that a linear fit fails.  
Case III: Heterogeneous catalysis 
This case differs from Case II in only one key respect: Catalysis can be carried out not only by 
the ICAT state of MUT, but also by the equivalent conformation of WT or other non-aggregation 
prone variant. Using the simple model of a bimolecular catalytic complex, which was validated 
in Case II, we have: 
[𝐼𝐶𝐴𝑇] = 𝐾𝐶𝐴𝑇[𝑁] 
𝑑[𝐼𝑆𝑆]
𝑑𝑡
= 𝑘𝑠𝑠([𝐼𝐶𝐴𝑇] + [𝐼𝐶𝐴𝑇
𝑊𝑇 ])[ 𝐼𝐶𝐴𝑇] − 𝑘𝐴[𝐼𝑆𝑆]
𝑛 
𝑑[𝐴]
𝑑𝑡
= 𝑘𝐴[𝐼𝑆𝑆]
𝑛 
Note that, since the non-aggregation prone variant (which we label “WT” for simplicity) does 
not proceed to the ISS conformational state, its population of ICAT is determined by an equilibrium 
process. The value of the equilibrium constant is variant-specific. 
[𝐼𝐶𝐴𝑇
𝑊𝑇 ] = 𝐾𝐶𝐴𝑇
𝑊𝑇 [𝑁𝑊𝑇] 
When the concentration of the mutant protein is kept constant, self-catalysis makes a constant 
contribution to the aggregation rate, while heterogeneous catalysis depends on [WT]: 
𝑑[𝐴]
𝑑𝑡
|
𝑚𝑎𝑥
= [ 𝐼𝐶𝐴𝑇](𝑘𝑆𝑆[𝐼𝐶𝐴𝑇
𝑊𝑇 ] + [ 𝐼𝐶𝐴𝑇]) ∝ [𝑁]([𝑁
𝑊𝑇] + 𝑐𝑜𝑛𝑠𝑡. ) 
In this case, the maximum aggregation rate depends linearly on the concentration of the WT 
protein, which is in excellent agreement with the data in Fig. 3B. The constant accounts for the 
fact that self-catalysis makes a modest but non-negligible contribution to the aggregation rate 
under these conditions. Note that the value of each rate constant above is specific to the given 
mutant. 
To assess the generality of the findings beyond W42Q, we tested two other variants of HγD: 
V75D and L5S. Even though the three mutations are in distal parts of the N-terminal domain’s 
sequence, all three are associated with cataract (41, 46, 56-58), and all three replace core 
hydrophobic residues with hydrophilic ones, thus destabilizing the N-terminal domain (see Table 
1). As expected, each variant showed redox-dependent aggregation comparable to that of W42Q, 
although higher protein concentrations were necessary to achieve comparable aggregation rates 
(Fig. 3A). This variation can be rationalized structurally, as described below.  
 Fig. 3. Dependence of maximal slope of kinetic turbidity curves on initial concentrations (in 
μM) for homogeneous aggregation of aggregation-prone W42Q, V75D, and L5S variants (self-
catalysis, A) and (B) heterogeneous catalysis of the same aggregation-prone variants by added 
WT. The concentration-dependence graphs in (A) are fit to lines of slope = 2 on the log-log plot, 
corresponding to quadratic parabolas in linear scale. The dashed line represents best linear fit 
(slope = 1) for comparison. Since a gentle acceleration of aggregation rate was observed at later 
times in the case of L5S, open squares show rates for this second phase. In (B) fits are linear as 
predicted by theory. WT appeared to be a stronger catalyst of L5S and V75 aggregation, but the 
distinction could be due to higher concentrations of these variants (noted on the plot) than for 
W42Q. (See Discussion.) 
Structural model of catalysis of HγD aggregation 
Examination of the structure, as well as previous simulations (41), indicated that the only 
partially unfolded conformation expected to be accessible in WT HγD under physiological 
conditions is the one where the cores of both domains are intact, but the domain interface is 
opened. We hypothesize that this conformation with open domain interface is active in 
conformational catalysis. The free energy of the domain interface has been estimated at just 4 
kcal/mol (52), so WT is expected to populate this intermediate, albeit rarely and transiently, 
under physiological conditions. The low population of this intermediate (low 𝐾𝐶𝐴𝑇
𝑊𝑇 ) explains the 
relatively high concentrations of WT required for catalysis of aggregation (Fig. 3B): it is not the 
native state WT that is catalytically active, but only the minor fraction that adopts the open-
interface intermediate conformation at any given time. 
To test the hypothesis of conformational catalysis via the interface, we prepared a series of four 
constructs expected to have distinct interface-opening propensities and evaluated their ability to 
catalyze W42Q aggregation. Construct 1 was WT bearing an N-terminal KHHHHHHQ tag 
sequence; this tag has been shown to interact with the domain linker and part of the C-terminal 
domain (59), so we reasoned it was likely to decrease the population of the open-interface 
intermediate. Construct 2 was the untagged WT protein as used elsewhere in this study. 
Construct 3 was the H83P variant, which introduces an extra Pro residue into the domain linker 
and is expected to increase linker strain. Construct 4 was the double-deletion variant ∆85,86, in 
which two of the five residues that form the domain linker are deleted, which is expected to 
result in large linker strain. Indeed, purification of the ∆85,86 variant revealed a modest shift 
toward earlier elution position by size-exclusion chromatography, consistent with a more open 
structure, and solutions of the ∆85,86 became cloudy if kept on ice, in contrast to all other 
crystalline constructs in this study; the cloudiness dissipated completely upon warming the 
sample to 37 °C or room temperature. The reversible nature of this aggregation process suggests 
reversible, likely domain-swapped, polymerization exclusively at cold temperatures.  
As shown in Fig. 4A, the oligomeric state of the four constructs varied in accordance with their 
expected interface-opening propensities: no detectable dimer in HisWT; an extremely weak 
dimer peak in WT; a strong one for H83P; and the ∆85,86 variant was almost entirely dimeric. 
Static light scattering experiments in batch mode confirmed the shift to dimeric structures, as 
indicated.  
The magnitude of conformational catalysis by these four constructs likewise ranked in 
accordance with their predicted propensity to populate the open-interface intermediate. HisWT 
was the least active, followed by WT, H83P, and finally ∆85,86 (Fig. 4B). Moreover, a mixture 
of isolated N- and C-terminal domains had a comparable catalytic activity to the ∆85,86 variant 
(Fig. 4C). Thus, the WT protein’s catalytic activity was indeed likely related to interface 
opening. 
While both isolated domains produced enhanced turbidity when mixed with the W42Q variant, 
the reasons for the enhancement were distinct. As shown in Fig. 4D, the isolated N-terminal 
domain co-aggregated with the W42Q variant, whereas the C-terminal domain did not. Likewise, 
the aggregated fraction in the W42Q/∆85,86 mixture contained ~10% ∆85,86, a minor but 
significant amount (Fig. S5). It is known that the domain interface in the native HγD structure 
disproportionately stabilizes the N-terminal domain, both thermodynamically and kinetically 
(reducing its rate of unfolding) (52, 60). Disrupting the stabilizing domain interface thus likely 
facilitates misfolding and disulfide-trapping of the N-terminal domain even in the absence of any 
mutations in the core, leading to the possibility of co-aggregation. Indeed, the isolated N-
terminal domain aggregated by itself at slightly elevated temperatures (42 °C), as shown in Fig. 
4E.  
The observation of co-aggregation between the N-terminal domain and W42Q, but no co-
aggregation with the C-terminal domain suggests the C-terminal side of the domain interface is 
responsible for conformational catalysis, and therefore no such catalysis would exist for the 
isolated N-terminal domain. Our kinetic model predicts linear concentration dependence of 
maximal aggregation rate in that case, and indeed that is what we observed (Fig. 4D), in contrast 
to the quadratic concentration dependence of self-aggregation in full-length variants (Fig. 3A). 
These data are consistent with the model whereby C-terminal domain interface of W42Q serves 
as a catalyst for aggregation, facilitating misfolding of the N-terminal domain in a bimolecular 
interaction. Indeed, molecular dynamics simulations have shown that the W42R mutation 
destabilizes not only the core of the N-terminal domain, but also the domain interface (55), thus 
facilitating population of the open-interface conformer and exposure of the C-terminal side of the 
domain interface. This accounts for the rapid homogeneous aggregation of W42Q compared to 
L5S (Fig. 3A). 
 
Fig. 4: Conformational catalysis is associated with the C-terminal side of the domain 
interface. (A) Extent of dimerization by size-exclusion chromatography was in the order of 
predicted interface-opening propensity. Samples were incubated with reducing agent prior to 
SEC. Dimerization was confirmed by static light scattering, as indicated by the apparent 
molecular weights in batch mode. (B) Aggregation-promoting ability of His-WT, WT, H83P, 
and ∆85,86 had the same rank order as expected accessibility of the domain interface. (C) The C-
terminal domain promoted aggregation most efficiently, although when N-td and W42Q were 
both present, aggregation was enhanced.to the same level as the ∆85,86 variant. (D) The N-
terminal domain co-aggregated with the W42Q variant in approximately stoichiometric amounts, 
whereas the C-terminal domain showed no co-aggregation. (E) The N-terminal domain 
aggregated by itself at a slightly elevated temperature (42 °C), but the concentration dependence 
of aggregation rate was linear, indicating absence of a catalytic process. 
 
Table 1: Thermostability of select HγD variants by differential scanning calorimetry 
Protein Tm 1 (N-td) Tm 2 (C-td) 
W42Q 
a
 54.6 ± 0.3 71.1 ± 1.7 
L5S 58.3 ± 0.02 70.5 ± 0.1 
V75D 60.0 ± 0.01 71.0 ± 0.02 
WT 81.2 ± 0.1 84.1 ± 0.03 
H83P 81.5 ± 0.1 84.2 ± 0.03 
∆85,86 71.6 ± 0.2 74.3 ± 0.04 
Transition midpoints were obtained by fitting the differential scanning calorimetry traces to a 
double-Gaussian model using the NanoDSC software. Values are reported as mean ± standard 
deviation of 2-3 technical replicates. 
a
Data from reference (41). 
 
To determine whether the catalytic effect on W42Q aggregation was due to specific features of 
the domain interface or to its overall hydrophobicity, we studied aggregation of W42Q in the 
presence of varying concentrations of bovine serum albumin (BSA). BSA natively has ~28 times 
more hydrophobic surface area per molecule than either of the HγD single domains (and ~60 
times more than native HγD WT), as summarized in Table S6. Some acceleration of W42Q 
aggregation was indeed observed in the presence of BSA (Fig. S7), but the HγD constructs, 
despite their much lower overall hydrophobicity, produced much more rapid aggregation than 
BSA, indicating that the conformational catalysis cannot be explained by mere hydrophobicity. 
Investigation of the isolated C-terminal domain provided a structural explanation for this 
catalytic mode of action of the C-terminal domain interface. It has been shown (61) that the 
isolated C-terminal domain of human γS-crystallin forms crystallographic dimers with a stable 
hydrophobic dimer interface composed of the same residues as the domain interface in the native 
state (Fig. 5A). We found that the HγD C-terminal domain also formed a dimer, eluting close to 
the full-length WT position by size-exclusion chromatography (Fig. 5B). Dimerization was 
confirmed by static light scattering in batch mode, as indicated. We propose that transient 
dimerization of HγD molecules in the open-interface intermediate state via formation of non-
native intermolecular C-td:C-td interfaces eliminates stabilization of the N-terminal domain 
through interface with more stable C-terminal domain and therefore facilitates misfolding of the 
N-terminal domains. In the case of WT that opening of the interface is too rare and transient, and 
the N-terminal domain core too stable, to generate detectable misfolding of the N-terminal 
domain core to form the aggregation-prone 32-SS-41 non-native disulfide. However, when the 
N-terminal domain core is destabilized by the W42Q or other cataract-associated mutations – or 
when interface opening is a permanent feature, as in the case of the ∆85,86 variant – the 
relatively labile N-terminal domain misfolds to populate the aggregation-prone intermediate. In 
this way, interaction of two HγD molecules in similar intermediate states (open-interface) 
facilitates their conversion into a distinct and more unfolded intermediate state (hairpin-
extruded) and thus accelerates aggregation. This structural model is summarized in Fig. 6.  
 Fig. 5: Homodimerization of the C-terminal domain is favored over N-td:C-td 
heterodimerization. (A) A comparison between the native-state N-td:C-td domain interface of 
HγD (PDB ID 1HK0) (49) and the interface of the HγS C-td dimer (PDB ID 1HA4) (61). Ile171 
and Phe172, in ball-and-stick representation in the HγD structure, would become available as 
part of a putative C-td-C-td interface. (B) Size-exclusion chromatography of isolated C-td (top), 
isolated N-td (middle), and a mixture of N-td and C-td following a 3.5 h incubation at 37 °C in 
the presence of DTT and ETDA. The mixture experiment did not result in an elution peak 
containing both N-td and C-td; rather, the two domains eluted separately, N-td as a monomer and 
C-td as a dimer, as confirmed by electrospray mass spectrometry. The C-td:C-td dimer therefore 
appears to outcompete the native-like N-td:C-td pairing. 
 
Discussion 
In previous work we have shown that both misfolding and formation of a nonnative internal 
disulfide are required for the aggregation process in cataract-associated variants of HγD (41, 53). 
This disulfide locks a specific aggregation-prone structure, and formation of the same disulfide 
was found to correlate with cataract severity (33). We have also shown the surprising ability of 
HγD, and likely other γ-crystallins, to dynamically exchange disulfide bonds, potentially serving 
as a redox buffer (42), for which there is also supporting evidence from lens proteomics (35, 40). 
The “hot potato” mechanism proposed in (42) asserts that WT HγD has an oxidoreductase 
activity by oxidizing other HγD molecules in a relay-like manner until a mutationally or post-
translationally destabilized HγD molecule gets oxidized with subsequent formation of the 32-SS-
41 disulfide causing irreversible aggregation and elimination of the disulfide from solution. This 
way oxidized WT promotes aggregation of W42Q or other destabilized variants.  
We have now shown that the WT remains a potent catalyst of W42Q aggregation even under 
strongly oxidizing condition (large excess of GSSG) suggesting an additional mechanism by 
which WT HγD can promote aggregation of mutant aggregation prone variants. Conversely, 
even oxidoreductase-inert versions of WT HγD (CCCC) dramatically increased aggregation 
kinetics and conformational dynamics of cataract-associated W42Q HγD. Aggregation of other 
cataract-associated variants (V75D and L5S) was accelerated even more. These findings suggest 
a novel mechanism by which WT promotes aggregation of cataract-associated variants – 
conformational catalysis. In the conformational catalysis mechanism, partial unfolding of one 
HγD molecule catalyzes misfolding of another. The observation of strong C-td:C-td association, 
combined with prior findings of significant destabilization of the isolated N-td, led us to propose 
that in HγD conformational catalysis proceeds by “interface stealing.” Our kinetic model based 
on the assumption that conformational catalysis accelerates monomolecular conversion of the 
native state to the aggregation-prone intermediate in the cataract-associated variant predicted a 
robust (independent of kinetic parameters) functional form of dependence of aggregation kinetics 
on initial concentration of aggregating and catalyst variants, and the data fully supported this 
prediction (Fig. 3).  
It's important to note the observed aggregation pathway does not depend on any particular 
mutation: oxidative aggregation under physiologically relevant conditions occurs not only for 
W42Q, but also for V75D, L5S, and even fully wild-type N-terminal domain, as long as the 
interface with the C-terminal domain has been disrupted. Disruption of the domain interface need 
not even require drastic damage, since it has been shown that one or two deamidations can be 
enough (51). These findings indicate that a variety of perturbations to diverse areas of the 
protein’s structure may all converge on similar partially unfolded aggregation-prone 
intermediates. 
Here we reported a peculiar structural mechanism of conformational catalysis which involves 
interface stealing by the catalyst protein from the aggregation-prone variant (Fig. 5B). Note that 
the two domains of the γ-crystallins arose by gene duplication and fusion (62); they are 
structurally identical, but their sequences have diverged (37% identity). Structural similarity 
promotes propensity of proteins to interact (63, 64). Further, it was shown that for structurally 
similar domains sequence divergence weakens their interactive propensity (65)consistent with 
our observation that homodimerization of C-td is more favorable than C-td:Ntd 
heterodimerization (Fig. 5B). The C-terminal domain of human γS-crystallin can form dimers 
(61), and in that protein, too, the resulting loss of the native domain interface greatly accelerates 
unfolding of the Cys-rich N-terminal domain (52, 60). Dimerization of the N-terminal domains 
via disulfides (66) may serve a protective function in this scenario. We expect that 
conformational catalysis like that presented here for HγD may also operate in HγS, other 
members of the γ-crystallin family, and perhaps other multidomain proteins.  
In WT proteins interface stealing is likely not prevalent for entropic reasons – due to the high 
effective concentration of the two domains tethered by only a 5-residue linker. Furthermore, it 
has been shown that protein stability contributes to the strength of interaction with other proteins 
(67, 68). Thus, when the N-td is destabilized as in aggregation-prone variants, the stability of N-
td:C-td interface is likely also weakened, making the intermolecular C-td:Ctd interface relatively 
more favorable. This is especially true for mutations at Trp42, which disrupt both the N-td core 
and the domain interface (55). This double disruption explains why W42Q is much more 
aggregation-prone than L5S or V75D despite relatively small differences in thermostability 
(Table 1) – the C-td:C-td mode of dimerization is especially favorable in W42Q, making it a 
potent self-catalyst. The L5S and V75D mutations are not at the domain interface, so their rates 
of self-catalyzed aggregation are lower, and aggregation is accelerated by the WT protein to a 
relatively greater extent. 
The phenomenon of conformational catalysis is conceptually the opposite of the by now well-
known case of conformational templating (as in prions). In the templating case, protein-protein 
interactions shift one protein molecule into the same conformation as another (69-71). In the 
present case, partially unfolded WT protein catalyzes the mutant’s conformational conversion to 
a state that the WT itself does not populate. “Inverse prion” interactions of this type have not 
been reported to our knowledge previously. Yet, they are likely to play a role in determining the 
properties of highly concentrated protein solutions. Conformational catalysis is expected to cause 
conformational heterogeneity to arise more rapidly at high protein concentrations than at low 
concentrations. This may promote non-native aggregation, but may also inhibit deleterious 
native-state aggregation, such as crystallization, which is an important evolutionary constraint in 
the lens (26, 49, 72). Future research should examine whether any defensive mechanisms have 
evolved to mitigate the aggregation-promoting effect of conformational catalysis. 
 
 
Fig. 6: Structural model of conformational catalysis. The catalytic interaction depends on a 
complex between cognate domains of two molecules (black), which deprives their partner 
domains (red, blue) of the added kinetic stability contributed by the native domain interface. If 
this partner domain also bears a destabilizing modification (white stripe), misfolding becomes 
likely. In the case of HγD, the misfolded conformer is locked by a non-native disulfide bond 
(green), while the wild-type intermediate is free to dissociate without further misfolding in a 
reaction driven by re-formation of the native domain interface. The aggregate model depicts the 
three recognized interaction modes between the detached N-terminal hairpin of HγD W42Q and 
sites on other copies of the protein, based on (41). 
 The general requirements for conformational catalysis to exist are relatively few. The mechanism 
presented here requires a multidomain protein where the stability of one domain is derived in 
part from its interface with another, and where interface stealing is possible. Besides interface 
stealing, classical domain swapping could also lead to a similar effect, as long as geometric or 
other constraints permit only a single swap, leaving one of the two destabilized domains 
unpaired. More generally, whenever a transient interaction between two protein molecules in a 
non-native conformational state further alters the conformation of one of them, conformational 
catalysis may be said to occur. Future research should investigate how significant a role 
conformational catalysis, and interface stealing in particular, may play in the stability, function, 
and aggregation of multidomain proteins. 
 
Methods 
Protein expression and purification  Expression and purification were carried out as 
described in (42). Briefly, untagged HγD constructs were expressed from the pET16b vector in 
BL-21 RIL cells in SuperBroth medium (Teknova). The cells were grown to late-log or early-
stationary phase to obtain the highest yields under our expression conditions. After lysis by 
sonication, the proteins were purified by ammonium sulfate fractionation (collecting the fraction 
between 30% and 50% ammonium sulfate), followed by ion exchange on a Q-sepharose column 
(GE Life Science) and size exclusion on a Superdex75 26x600 column (GE Life Science) in the 
standard sample buffer, 10 mM ammonium acetate with 50 mM sodium chloride, pH 7. The 
three mutants whose aggregation traces were used in Figure 3 were treated with a reducing agent 
(1 mM dithiothreitol) for 2 h at room temperature prior to size exclusion. 
Solution turbidity assays and fitting  Turbidity assays were carried out as described in 
(42). All samples contained 1 mM EDTA to inhibit any trace metal-induced aggregation as seen 
in (73-75). Sample volume was 100 μl in half-area polypropylene plates (Greiner Bio-One), 
resulting in a path length of ~0.4 cm at the meniscus. Readings were taken in 96-well format on 
the PowerWave HT plate reader (BioTek). Maximum rate of turbidity was defined as the slope 
of the steepest tangent, which occurred early in the turbidity trace. Threshold values of turbidity 
were determined empirically for each mutant; linear regression fits were applied to the 10 time 
points starting 1, 2, and 3 points post-threshold. The resulting slopes were averaged. Fits to the 
maximum rate vs. concentration data used linear regression of the form y = ax
2
, with a as the 
only fitting parameter. Turbidity thresholds were set at 0.04 for W42Q; 0.02 for V75D; and 
0.005 and 0.1 for L5S, since the aggregation of that variant appeared biphasic (see Fig. S4). 
PEGylation assays  Cys-accessibility PEGylations were carried out as follows. W42Q (20 μM) 
was incubated with or without the C18T/C78A/C108S/C110S variant (100 μM) and PEG(5000)-
maleimide (500 μM) (Sigma) in standard sample buffer at 37 °C in the absence of any oxidizing 
agent. 5-μl samples were taken at the time points indicated (Fig. 2 and Fig. S3) and mixed with 
15 μl of denaturing buffer containing 5 μl 4x Tris/SDS NuPAGE gel-loading buffer (Thermo 
Fisher), 10 mM tricarboxyethyl phosphine (TCEP) as the reducing agent, and 1 mM L-Cysteine 
as the quencher of PEG-maleimide. The denaturing buffer was prepared the day of the 
experiment and allowed to equilibrate for 1 h prior to use to ensure all L-Cysteine was in its 
reduced form. Three or four replicate samples were used in each case. Cys-counting PEGylations 
were carried out as described in (42), in the presence of reducing agent (1 mM TCEP). Minor 
bands at +4PEG in Figure 1E indicate the reduction of internal disulfide bonds in W42Q was still 
not 100% complete, possibly because some bonds remained buried during the reductive 
treatment. 
Analytical size-exclusion chromatography  Samples at 10 μM concentration in standard 
sample buffer were incubated at 37 °C with 1 mM DTT and 1 mM EDTA for between 2 and 3.5 
h. In the case of the N+C mixture the concentration was 10 μΜ of each. 100 μl of each sample 
was injected on the Superdex 75 10x300 analytical column (GE Life Science) in standard sample 
buffer, and peak fractions were collected manually. 
Differential scanning calorimetry  A nanoDSC robotic calorimeter (TA Instruments) was 
used, following the procedure in (41). Samples were buffer-exchanged by dialysis to 20 mM 
sodium phosphates, 50 mM NaCl buffer. Reducing agent (1 mM TCEP) was added prior to the 
experiments. 
Mass spectrometry  MALDI-TOF mass spectrometry was carried out following the protocol of 
(76) using a stainless steel target plate (Bruker) and the Bruker Ultraflextreme mass 
spectrometer. Pelleted samples were partially resolubilized with 0.1 M pH 5 ammonium acetate 
buffer. Samples were desalted using Pierce C18 tips (Thermo Fisher) and eluted in 80% 
acetonitrile with 0.1% trifluoroacetic acid. For electrospray mass spectrometry, samples from the 
size-exclusion were desalted using Pierce C18 tips (Thermo Fisher), eluted in 80% acetonitrile 
with 1% formic acid, and analyzed by LC/MS on an Agilent 6210 electrospray mass 
spectrometer, followed by maximum entropy deconvolution with 1 Da step and boundaries of 
7,000-25,000 Da. 
Static light scattering  Samples at concentrations of 40 μM or (for C-td) 100 μM in 
standard sample buffer were treated with 1 mM DTT for ~1 h at room temperature to remove any 
possible C110-C110 dimers. They were then analyzed in 50-100 μl volume on the NanoStar 
dynamic light scattering instrument (Wyatt) in static light scattering mode, using disposable 
cuvettes from the manufacturer. The autocorrelation functions were deconvoluted using the 
Wyatt Dynamics software with the following restraints: 1.5-200 μs correlation times and 1.0-4.0 
nm hydrodynamic radii. At least 20 measurements were averaged for each sample. 
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Supplementary Information 
 
Fig. S1: Oxidation status of WT does not affect its ability to catalyze W42Q aggregation when excess GSSG is 
present. We have previously shown (ref. 42) that in the absence of any oxidation WT does not promote 
aggregation of W42Q, and that this aggregation requires non-native disulfide formation in W42Q (ref. 41). GSSG 
alone promoted W42Q aggregation, and so did oxidized WT, both consistent with these prior reports. However, 
the effect of GSSG + WT, or the WT protein alone if oxidized, was far greater than that of GSSG alone at the same 
concentration. Indeed, oxidation status of WT made no difference if excess GSSG was present in the sample. 
 
 
Fig. S2: Aggregates formed in the WT + W42Q + GSSG mixture contain only W42Q. MALDI-TOF spectral region 
containing the z = 2 ion confirmed that the starting mixture (black) contained both W42Q and WT, with an excess 
of the latter; the pelletable fraction contained only W42Q (red); and the remaining supernatant (green) contained 
the same amount of WT, but less W42Q, compared to the starting mixture. 
 
Fig. S3: Solvent accessibility of buried Cys residues in the W42Q N-terminal domain increases in the presence of 
WT analog. (A, C, D) The W42Q mutant sample was incubated with the WT-like quadruple Cys variant 
C18T/C78A/C108S/C110S and PEG-maleimide, and samples taken at indicated time points were analyzed by SDS-
PAGE with subsequent quantitation by gel densitometry using GelAnalyzer 2010 software (B). Quantitation of the 
gels shown in (C) and (D) is presented in Fig. 2. 
 
 
 
 
Fig. S4: Turbidity traces for homogeneous and heterogeneous (WT-catalyzed) aggregation of the L5S, W42Q, and 
V75D variants. Concentration of the variable protein increases from blue to red, with the lowest and highest 
concentrations indicated. Top row: Aggregation of L5S was assayed at concentrations from 40 to 140 μM, with a 
step of 10 μM; W42Q was assayed from 10 to 60 μM, with a step of 5 μM; V75D was assayed from 100 to 400 μM, 
with a step of 30 μM. Bottom row: Variable amounts of WT protein were added to a fixed amount of each mutant. 
[WT] was varied from 0 to 275 μM, with a step of 25 μM. 
 
 
  
Fig. S5: Coaggregation was observed between W42Q and ∆85,86 (B), but not between W42Q and H83P (A) in 
deconvoluted whole-protein electrospray mass spectra. Supernatant (“SUP”) and pellet (“PEL”) fractions from each 
aggregation experiment were analyzed. *Since their masses are too similar, the W42Q single oxidation (+16 Da.) 
peak and the native H83P peak cannot be reliably resolved on the Agilent 6220 instrument. However, comparison 
to the PEL sample in (B), where no H83P is present, suggests that any co-aggregation of W42Q with H83P is at or 
below the limit of detection. 
 
 
Table S6: Solvent-accessible hydrophobic surface area of HγD WT compared to its isolated domains and to BSA  
Protein SASA, Å
2 
HγD WT 474 
HγD N-terminal domain 1126 
HγD C-terminal domain 971 
BSA 5415 
Visual Molecular Dynamics (VMD) software (U. Illinois) was used to calculate the sum of solvent-accessible surface 
area belonging to W, F, L, I, V, M, A, or P residues in HγD WT (PDB ID 1hk0), its isolated domains (by removing the 
cognate domain from the same PDB structure), and bovine serum albumin (BSA) monomer (PDB ID 3v03).  
 
 
 
Fig. S7: Conformational catalysis is not due to surface hydrophobicity. (A) Aggregation traces of W42Q with 
variable concentration (from 0 to 200 μM, with a step of 20 μM) of H83P revealed much greater turbidity than (B) 
the same in the presence of variable [BSA] from three separate batches as indicated. The BSA protein was 
prepared each time by dissolving several milligrams of BSA powder (Sigma), followed by size-exclusion 
chromatography, isolation and concentration of the monomer fraction. (C) Modest co-aggregation was observed 
between BSA and W42Q by pellet/supernatant separation. This could be attributable to disulfide-mediated cross-
linking between the two proteins. (D) While presence of BSA did accelerate the maximum aggregation rate of 
W42Q, the effect was both smaller and much less dose-dependent than for H83P; furthermore, the lag time of 
aggregation, defined as the x-intercept of the steepest tangent, was significantly longer in the case of BSA. 
 
